Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
This week’s research roundup features a study on the utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
On the road again: COVID-19 safety tips for commuters
Top highlights include: Why it's critical for children to get their routine health care, infographic on how soap kills COVID-19, and how meditation can help with stress relief.
Mayo Clinic has launched a new SARS-CoV-2 neutralizing antibody test in support of the nationwide convalescent plasma exchange study and other critical research efforts to establish effective therapies and vaccines for COVID-19. The test will be available through Mayo Clinic Laboratories to select labs, blood banks, and biopharma clients in late June.
Top highlights include: Mayo Clinic launches neutralizing antibody test to advance COVID-19 therapies, Dr. Bobbi Pritt explains who should get COVID-19 testing, and a new Answers from the Lab podcast featuring Dr. Bill Morice.
Top highlights include: Health care leaders urge patients to seek necessary care and the Mayo Clinic Q&A podcast discusses medical education during the COVID-19 pandemic.
Top highlights include: Precautions for a summer of COVID-19 and the importance of self-care during difficult times.
This week’s research roundup features a study on headaches in the older population: causes, diagnoses, and treatments.
Top highlights include: Repetitive motion injuries during COVID-19 and remote patient monitoring provides patients with comprehensive care at home.
COVID-19: Four dimensions of safety during these unprecedented times.
Andre Oliveira, M.D., Ph.D., gives an overview of this testing available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action can be taken due to the results of this testing.
As we enter a second week of protest and unrest throughout the nation sparked by the deaths of George Floyd and Ahmaud Arbery, we want to recognize the heartache and pain felt because of these events. Added to the uncertainty with navigating COVID-19, these troubling incidents have understandably invoked feelings of anger, frustration, sadness, and fear.